Startseite
Aktuelles Heft
Heftauswahl
Aktuelle Literatur
Guidelines
Wissenschaftl. Beirat
Springer-Verlag
Impressum
Fachbereich

Evidenz der komplementären und Alternativmedizin (CAM) in der Therapie des Mammakarzinoms – Vollständige Referenzliste – GynSpectrum 3/2006

Prof. Bernd Gerber, Rostock 


Reference List

  1. Gerber B, Scholz C, Reimer T, Briese V, Janni W: Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat 2006;95:199-209.
  2. NCAM. http://www.nccam.nih.gov . 2006.
  3. Oxford Centre for Evidence-based Medicine Levels of Evidence: Levels of Evidence and Grades of Recommendation. http://www.cebm.net/levels_of_evidence.asp 2006.
  4. Baum M, Cassileth BR, Daniel R, Ernst E, Filshie J, Nagel GA, Horneber M, Kohn M, Lejeune S, Maher J, Terje R, Smith WB: The role of complementary and alternative medicine in the management of early breast cancer: Recommendations of the European Society of Mastology (EUSOMA). Eur J Cancer 2006.
  5. Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD: Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study. Breast Cancer Res Treat 2006.
  6. Navo MA, Phan J, Vaughan C, Palmer JL, Michaud L, Jones KL, Bodurka DC, Basen-Engquist K, Hortobagyi GN, Kavanagh JJ, Smith JA: An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol 2004;22:671-677.
  7. Baum M, Ernst E, Lejeune S, Horneber M: Role of complementary and alternative medicine in the care of patients with breast cancer: Report of the European Society of Mastology (EUSOMA) Workshop, Florence, Italy, December 2004. Eur J Cancer 2006.
  8. Catt S, Fallowfield L, Langridge C: What non-prescription treatments do UK women with breast cancer use? Eur J Cancer Care (Engl ) 2006;15:279-285.
  9. van der WF, Streuli RA: Use of alternative medicine by patients with cancer in a rural area of Switzerland. Swiss Med Wkly 2003;133:233-240.
  10. Tagliaferri M, Cohen I, Tripathy D: Complementary and alternative medicine in early-stage breast cancer. Semin Oncol 2001;28:121-134.
  11. Johansson S, Gullbo J, Lindholm P, Ek B, Thunberg E, Samuelsson G, Larsson R, Bohlin L, Claeson P: Small, novel proteins from the mistletoe Phoradendron tomentosum exhibit highly selective cytotoxicity to human breast cancer cells. Cell Mol Life Sci 2003;60:165-175.
  12. Semiglazov VF, Stepula VV, Dudov A, Schnitker J, Mengs U: Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer Res 2006;26:1519-1529.
  13. Kienle GS, Berrino F, Bussing A, Portalupi E, Rosenzweig S, Kiene H: Mistletoe in cancer - a systematic review on controlled clinical trials. Eur J Med Res 2003;8:109-119.
  14. Gerhard I, Abel U, Loewe-Mesch A, Huppmann S, Kuehn JJ: Problems of randomized studies in complementary medicine demonstrated in a study on mistletoe treatment of patients with breast cancer. Forsch Komplementarmed Klass Naturheilkd 2004;11:150-157.
  15. Kovacs E: The in vitro effect of Viscum album (VA) extract on DNA repair of peripheral blood mononuclear cells (PBMC) in cancer patients. Phytother Res 2002;16:143-147.
  16. Gabius S, Gabius HJ: [Lectin-related use of mistletoe: an experimental form of treatment with preclinically demonstrated potential risks]. Dtsch Med Wochenschr 2002;127:457-459.
  17. Peeters PH, Keinan-Boker L, van der Schouw YT, Grobbee DE: Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res Treat 2003;77:171-183.
  18. Liu B, Edgerton S, Yang X, Kim A, Ordonez-Ercan D, Mason T, Alvarez K, McKimmey C, Liu N, Thor A: Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Cancer Res 2005;65:879-886.
  19. Allred CD, Allred KF, Ju YH, Goeppinger TS, Doerge DR, Helferich WG: Soy processing influences growth of estrogen-dependent breast cancer tumors in mice. Carcinogenesis 2004.
  20. Veronesi U, De Palo G, Marubini E, Costa A, Formelli F, Mariani L, Decensi A, Camerini T, Del Turco MR, Di Mauro MG, Muraca MG, Del Vecchio M, Pinto C, D'Aiuto G, Boni C, Campa T, Magni A, Miceli R, Perloff M, Malone WF, Sporn MB: Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst 1999;91:1847-1856.
  21. Lesperance ML, Olivotto IA, Forde N, Zhao Y, Speers C, Foster H, Tsao M, Macpherson N, Hoffer A: Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study. Breast Cancer Res Treat 2002;76:137-143.
  22. Saintot M, Mathieu-Daude H, Astre C, Grenier J, Simony-Lafontaine J, Gerber M: Oxidant-antioxidant status in relation to survival among breast cancer patients. Int J Cancer 2002;97:574-579.
  23. Food and Nutrition Board, Institute of Medicine: http://www.iom.edu/board.asp?id=3788 2006.
  24. Simopoulos AP: The traditional diet of Greece and cancer. Eur J Cancer Prev 2004;13:219-230.
  25. Woo W, Xu Z: Effect of dietary zinc intake on N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Biol Trace Elem Res 2001;83:169-179.
  26. Beuth J, Ost B, Pakdaman A, Rethfeldt E, Bock PR, Hanisch J, Schneider B: Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients--results of an epidemiological multicentre retrolective cohort study. Cancer Chemother Pharmacol 2001;47 Suppl:S45-S54.
  27. Campbell MJ, Hamilton B, Shoemaker M, Tagliaferri M, Cohen I, Tripathy D: Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. Anticancer Res 2002;22:3843-3852.
  28. Suzuki Y, Tsubono Y, Nakaya N, Suzuki Y, Koizumi Y, Tsuji I: Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer 2004;90:1361-1363.
  29. Sparreboom A, Cox MC, Acharya MR, Figg WD: Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 2004;22:2489-2503.
  30. Rockwell S, Liu Y, Higgins SA: Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh. Breast Cancer Res Treat 2005;90:233-239.
  31. Helyer LK, Chin S, Chui BK, Fitzgerald B, Verma S, Rakovitch E, Dranitsaris G, Clemons M: The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study. BMC Cancer 2006;6:39.
  32. Seo HS, Denardo DG, Jacquot Y, Laios I, Vidal DS, Zambrana CR, Leclercq G, Brown PH: Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Res Treat 2006.
  33. Risberg T, Vickers A, Bremnes RM, Wist EA, Kaasa S, Cassileth BR: Does use of alternative medicine predict survival from cancer? Eur J Cancer 2003;39:372-377.
  34. AGO. http://www.ago-online.org  2006.


« zurück

Artikel-Suche
UND ODER
Termine
16.03.2011 - 19.03.2011
St. Gallen - 12th International Conference Primary Therapy of Early Breast Cancer
 St. Gallen, Schweiz
 zur Seite...